Motus Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: Boston MA United States (2008)
Status: Acquired by Allergan PLC (2015) (2016) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2011
NCT01394055
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Motus Melior | Motus Melior, Ltd.